Transplantation for hepatocellular carcinoma: more haste, less speed?

Tian Yang^{1

2}, Wan Yee Lau^{1

3}, Bin Huang¹, Myron Schwartz², Feng Shen¹

Affiliations

¹ Clinical Epidemiology and Research Center Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
² Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
³ Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Comment

Tian Yang et al. Hepatology. 2015 Oct.

. 2015 Oct;62(4):1327-8.

doi: 10.1002/hep.27820. Epub 2015 May 9.

Tian Yang^{1

2}, Wan Yee Lau^{1

3}, Bin Huang¹, Myron Schwartz², Feng Shen¹

¹ Clinical Epidemiology and Research Center Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
² Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
³ Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

No abstract available

Comment in

Reply: To PMID 24954365.
Halazun KJ, Patzer RE, Rana AA, Samstein B, Brown RS Jr, Emond JC. Halazun KJ, et al. Hepatology. 2015 Oct;62(4):1328-9. doi: 10.1002/hep.27818. Epub 2015 May 13. Hepatology. 2015. PMID: 25823533 No abstract available.

Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment.
Halazun KJ, Patzer RE, Rana AA, Verna EC, Griesemer AD, Parsons RF, Samstein B, Guarrera JV, Kato T, Brown RS Jr, Emond JC. Halazun KJ, et al. Hepatology. 2014 Dec;60(6):1957-62. doi: 10.1002/hep.27272. Epub 2014 Sep 10. Hepatology. 2014. PMID: 24954365